RECURSION PHARMACEUTICALS, INC. Quarterly Long-term Debt and Lease Obligation in USD from Q4 2023 to Q2 2024

Taxonomy & unit: us-gaap: USD
Description: Amount of long-term debt and lease obligation, classified as noncurrent.
Summary: Recursion Pharmaceuticals, Inc. quarterly Long-term Debt and Lease Obligation history and growth rate from Q4 2023 to Q2 2024.
Recursion Pharmaceuticals, Inc. Long-term Debt and Lease Obligation for the quarter ending June 30, 2024 was $22.9M.

Long-term Debt and Lease Obligation, Quarterly (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q2 2024	$22.9M			Jun 30, 2024	10-Q	2024-08-08
Q4 2023	$1.1M			Dec 31, 2023	10-Q	2024-08-08

* An asterisk sign (*) next to the value indicates that the value is likely invalid.